Clinical trials of treatments for stroke
- Cite this article as:
- Blass, J. Curr Atheroscler Rep (2002) 4: 265. doi:10.1007/s11883-002-0004-8
- 16 Downloads
The “gold standard” for therapeutic trials is the prospective, double-blind, placebo-controlled, multicenter trial. However, they are relatively clumsy instruments for discovering innovative new treatments. This article briefly reviews selected clinical trials of treatments for stroke, including stroke rehabilitation, published during 2001 and the first 2 months of 2002. It also reviews other types of studies, including close observations of single patients, which can have a valuable role in generating useful new knowledge.